SCHEMBL2910340

SCHEMBL2910340

Nc1nc(NCCCn2cc(C(=O)NCCCn3ccnc3)c(-c3ccc(Cl)cc3Cl)c2)ccc1[N+](=O)[O-]

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 5/20 0.53
GSK3A P49840 3/20 0.53
CDK1 P06493 2/20 0.53
MAPT P10636 4/20 0.48
ALDH1A1 P00352 4/20 0.47
CYP19A1 P11511 1/20 0.46
LMNA P02545 2/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
CCNB2 O95067 1/20 0.44
CCNB1 P14635 1/20 0.44
CCNB3 Q8WWL7 1/20 0.44
MAPK1 P28482 2/20 0.44
HTT P42858 1/20 0.44
KDM4E B2RXH2 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
USP2 O75604 1/20 0.42
ALOX12 P18054 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2910223 0.90 GSK3B (0.48) GSK3BGSK3ACDK1MAPTALDH1A1
SCHEMBL2911606 0.90 GSK3B (0.48) GSK3BGSK3ACDK1MAPTALDH1A1
SCHEMBL2909523 0.90 GSK3B (0.48) GSK3BGSK3ACDK1MAPTALDH1A1
SCHEMBL2907243 0.89 GSK3B (0.46) GSK3BGSK3ACDK1MAPTLMNA
SCHEMBL2904013 0.88 GSK3B (0.52) GSK3BGSK3ACDK1MAPTALDH1A1
SCHEMBL2911772 0.88 GSK3B (0.52) GSK3BGSK3ACDK1MAPTALDH1A1
SCHEMBL2910685 0.88 GSK3B (0.49) GSK3BGSK3ACDK1MAPTALDH1A1
SCHEMBL2904255 0.88 GSK3B (0.47) GSK3BGSK3ACDK1MAPTALDH1A1
SCHEMBL2912130 0.88 GSK3B (0.48) GSK3BGSK3ACDK1MAPTALDH1A1
SCHEMBL2941039 0.87 GSK3B (0.48) GSK3BGSK3ACDK1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537099-B1 PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 NOVARTIS VACCINES & DIAGNOSTIC (US) 2010-08-11 EP disclosed